Search research articles
Contact Us
Filters
Showing results (351-360 of 383) with videos related to
Page
of 39
Sort By:
BMJ Open
|
May 3, 2022
Effects of temporarily suspending low-dose methotrexate treatment for 2 weeks after SARS-CoV-2 vaccine booster on vaccine response in immunosuppressed adults with inflammatory conditions: protocol for a multicentre randomised controlled trial and nested mechanistic substudy (Vaccine Response On/Off Methotrexate (VROOM) study)
Abhishek Abhishek, R J Boyton, Áine McKnight, et al.
Frontiers in Immunology
|
March 6, 2020
Strong CD4 T Cell Responses to Zika Virus Antigens in a Cohort of Dengue Virus Immune Mothers of Congenital Zika Virus Syndrome Infants
Catherine J Reynolds, Patricia Watber, Camilla Natália Oliveira Santos, et al.
The Lancet. Respiratory Medicine
|
June 30, 2022
Effect of a 2-week interruption in methotrexate treatment versus continued treatment on COVID-19 booster vaccine immunity in adults with inflammatory conditions (VROOM study): a randomised, open label, superiority trial
Abhishek Abhishek, Rosemary J Boyton, Nicholas Peckham, et al.
Plos Pathogens
|
May 3, 2014
Anthrax lethal factor as an immune target in humans and transgenic mice and the impact of HLA polymorphism on CD4+ T cell immunity
Stephanie Ascough, Rebecca J Ingram, Karen K Chu, et al.
Journal for Immunotherapy of Cancer
|
October 1, 2021
Trans-arterial chemoembolization as a loco-regional inducer of immunogenic cell death in hepatocellular carcinoma: implications for immunotherapy
David J Pinato, Sam M Murray, Alejandro Forner, et al.
Cell Reports Methods
|
August 17, 2022
Quantitative, multiplexed, targeted proteomics for ascertaining variant specific SARS-CoV-2 antibody response
Ivan Doykov, Tomas Baldwin, Justyna Spiewak, et al.
The Lancet. Microbe
|
July 12, 2021
Blood transcriptional biomarkers of acute viral infection for detection of pre-symptomatic SARS-CoV-2 infection: a nested, case-control diagnostic accuracy study
Rishi K Gupta, Joshua Rosenheim, Lucy C Bell, et al.
The Lancet. Gastroenterology & Hepatology
|
December 8, 2022
Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort study
Zhigang Liu, Kaixing Le, Xin Zhou, et al.
Communications Medicine
|
April 29, 2026
Current status and future perspectives on the mechanistic and pathophysiological understanding of long COVID
Mark A Faghy, Rob C I Wüst, Daniel M Altmann, et al.
Cell Reports
|
May 31, 2024
A targeted single mutation in influenza A virus universal epitope transforms immunogenicity and protective immunity via CD4<sup>+</sup> T cell activation
Sarah Hulin-Curtis, James K Geary, Bruce J MacLachlan, et al.
Page
of 39
Search research articles
Search
Showing results (351-360 of 383) with videos related to
Sort By:
Page
of 39
BMJ Open
|
May 3, 2022
Effects of temporarily suspending low-dose methotrexate treatment for 2 weeks after SARS-CoV-2 vaccine booster on vaccine response in immunosuppressed adults with inflammatory conditions: protocol for a multicentre randomised controlled trial and nested mechanistic substudy (Vaccine Response On/Off Methotrexate (VROOM) study)
Abhishek Abhishek, R J Boyton, Áine McKnight, et al.
Frontiers in Immunology
|
March 6, 2020
Strong CD4 T Cell Responses to Zika Virus Antigens in a Cohort of Dengue Virus Immune Mothers of Congenital Zika Virus Syndrome Infants
Catherine J Reynolds, Patricia Watber, Camilla Natália Oliveira Santos, et al.
The Lancet. Respiratory Medicine
|
June 30, 2022
Effect of a 2-week interruption in methotrexate treatment versus continued treatment on COVID-19 booster vaccine immunity in adults with inflammatory conditions (VROOM study): a randomised, open label, superiority trial
Abhishek Abhishek, Rosemary J Boyton, Nicholas Peckham, et al.
Plos Pathogens
|
May 3, 2014
Anthrax lethal factor as an immune target in humans and transgenic mice and the impact of HLA polymorphism on CD4+ T cell immunity
Stephanie Ascough, Rebecca J Ingram, Karen K Chu, et al.
Journal for Immunotherapy of Cancer
|
October 1, 2021
Trans-arterial chemoembolization as a loco-regional inducer of immunogenic cell death in hepatocellular carcinoma: implications for immunotherapy
David J Pinato, Sam M Murray, Alejandro Forner, et al.
Cell Reports Methods
|
August 17, 2022
Quantitative, multiplexed, targeted proteomics for ascertaining variant specific SARS-CoV-2 antibody response
Ivan Doykov, Tomas Baldwin, Justyna Spiewak, et al.
The Lancet. Microbe
|
July 12, 2021
Blood transcriptional biomarkers of acute viral infection for detection of pre-symptomatic SARS-CoV-2 infection: a nested, case-control diagnostic accuracy study
Rishi K Gupta, Joshua Rosenheim, Lucy C Bell, et al.
The Lancet. Gastroenterology & Hepatology
|
December 8, 2022
Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort study
Zhigang Liu, Kaixing Le, Xin Zhou, et al.
Communications Medicine
|
April 29, 2026
Current status and future perspectives on the mechanistic and pathophysiological understanding of long COVID
Mark A Faghy, Rob C I Wüst, Daniel M Altmann, et al.
Cell Reports
|
May 31, 2024
A targeted single mutation in influenza A virus universal epitope transforms immunogenicity and protective immunity via CD4<sup>+</sup> T cell activation
Sarah Hulin-Curtis, James K Geary, Bruce J MacLachlan, et al.
Page
of 39